The Board of Directors of Baxter International Inc. today declared a quarterly dividend of $0.26 per share of Baxter common stock.
This payment represents a continuation of the current rate, which was increased last quarter by 20 percent. This quarterly dividend is payable on April 1, 2009, to shareholders of record as of the close of business on March 10, 2009.
Baxter International Inc., through its subsidiaries, assists healthcare professionals and their patients with the treatment of complex medical conditions, including hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other conditions. The company applies its expertise in medical devices, pharmaceuticals and biotechnology to make a meaningful difference in patients’ lives.
Source: Baxter International
published: February 17, 2009 in: Baxter, Companies, Financial, Products